December is the third-best month of the year for the stock market historically There are a number of stocks that consistently beat the market by a wide margin during this month We...
Eli Lilly And Co’s stock saw a notable surge, trading at $610.50, up 1.69% (+$10.14) today, following the Food and Drug Administration’s approval of their blockbuster drug...
Eli Lilly and Novo Nordisk continue to capitalize on unprecedented interest in weight-loss drugs, with both companies posting strong Q3 results on Thursday. Pharmaceutical...
Each one of these five companies has beat the performance of the S&P 500 year-to-date. And they have amazing earnings surprise track records, including one that has a 5-year...
Several drugmakers have been thriving on the ongoing weight-loss trend, with Denmark's Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) standing out in particular. With over a...